FDCSP and mesenchymal cell neoplasm: In conclusion, by a combined approach of next generation sequencing and high throughput immunohistochemistry we identified two novel markers for FDC-S, FDCSP and SRGN, and suggested a highly effective and ready-to-use approach for its differential diagnosis with other mesenchymal tumors.